Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cibus Inc CBUS

Healthcare Biotechnology
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant... see more

Recent & Breaking News (NDAQ:CBUS)

Calyxt Reports 2nd Quarter Financial Results

Business Wire August 6, 2019

Calyxt to Hold Second Quarter Investor Conference Call on Wednesday, August 7, at 8:30 a.m. EDT - 7:30 a.m. CDT

Business Wire July 22, 2019

Calyxt® Reiterates 2019 Guidance and Gives Business Update During June 25 Investor Day

Business Wire June 25, 2019

Calyxt® Enters Commercial Soybean Crushing Agreement with Landus Cooperative

Business Wire June 24, 2019

Calyxt to Host Investor & Analyst Day on June 25, 2019

Business Wire June 11, 2019

Calyxt Appoints Dr. Travis Frey as Chief Technology Officer

Business Wire May 15, 2019

Calyxt Reports 1st Quarter Financial Results

Business Wire May 7, 2019

Dr. Dan Voytas, Co-Founder & Chief Science Officer of Calyxt, Elected to the National Academy of Sciences

Business Wire May 6, 2019

Calyxt to Hold First Quarter Investor Conference Call on Wednesday, May 8, at 8:30 a.m. EDT - 7:30 a.m. CDT

Business Wire April 29, 2019

Calyxt Reports 4th Quarter and Full Year 2018 Financial Results

Business Wire March 11, 2019

Calyxt to Hold Fourth Quarter and Full-Year 2018 Investor Conference Call on Tuesday, March 12, at 8:30 a.m. EDT – 7:30 a.m. CDT

Business Wire March 5, 2019

First Commercial Sale of Calyxt High Oleic Soybean Oil on the U.S. Market

Business Wire February 26, 2019

Calyxt and Agtegra Cooperative Announce Strategic Collaboration to Distribute Calyxt High Oleic Soybean

Business Wire February 19, 2019

Calyxt Names Debra Frimerman as General Counsel

Business Wire January 28, 2019

Kimberly Nelson Appointed to Calyxt Board of Directors

Business Wire January 23, 2019

Calyxt Doubles 2018 High Oleic Soybean Acres

Business Wire January 22, 2019

Calyxt Appoints Veteran Finance Executive, William F. Koschak, as Chief Financial Officer

Business Wire January 3, 2019

Calyxt Receives EU Patent on Use of CRISPR/Cas9 for Genome Editing in Plants

Business Wire December 17, 2018

Report: Exploring Fundamental Drivers Behind Reata Pharmaceuticals, Calyxt, SIFCO Industries, EchoStar, Tel-Instrument Electronics, and United States Antimony — New Horizons, Emerging Trends, and Upcoming Developments

GlobeNewswire November 26, 2018

Calyxt Reports Financial Results for Third Quarter 2018

Business Wire November 13, 2018